Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / Lung and Upper Aerodigestive Cancers Research Group / Identification of an autoantibody panel of markers (c-Myc, Cyclin A, Cyclin B1, Cyclin D1, CDK2 and Suvivin) for early detection of lung cancer.

Identification of an autoantibody panel of markers (c-Myc, Cyclin A, Cyclin B1, Cyclin D1, CDK2 and Suvivin) for early detection of lung cancer.

Announcement 10/27/2016

Thank you to everyone who contributed to the successful and productive EDRN Orientation Meeting in October. The next EDRN Steering Committee Meeting will take place in March 6-9, 2017 in Tempe, AZ. More information about this meeting will be available soon.

Announcement